Harm from Stenting of Symptomatic Intracranial Arterial Stenoses



Harm from Stenting of Symptomatic Intracranial Arterial Stenoses







BACKGROUND

Atherosclerotic intracranial arterial stenosis represents a common cause of ischemic stroke. Patients with severe stenosis are at a high risk of recurrent stroke in the territory supplied by the stenotic artery. Percutaneous transluminal angioplasty and stenting (PTAS) of intracranial arterial stenosis was increasingly used to prevent recurrent strokes. At the time of this study, there was uncertainty regarding the optimal treatment of intracranial arterial stenosis with aggressive medical therapy alone vs. in combination with PTAS.


OBJECTIVES

To compare maximum medical therapy with PTAS for secondary ischemic stroke prevention in recently symptomatic patients with intracranial arterial stenosis.


METHODS

Prospective, randomized study at 50 centers across the United States between 2008 and 2011.


Patients

451 patients who experienced a TIA or nondisabling stroke secondary to an angiographically confirmed stenosis of 70% to 90% within 30 days before enrollment were randomized. There was no significant difference in the degree of stenosis or location of the qualifying artery between groups.

Oct 13, 2018 | Posted by in NEUROLOGY | Comments Off on Harm from Stenting of Symptomatic Intracranial Arterial Stenoses

Full access? Get Clinical Tree

Get Clinical Tree app for offline access